Immunocompromised Patients
10.1155/2019/7313706

Burkitt Lymphoma of the Duodenum: An Uncommon Phenomenon


Immunocompromised Patients
10.3389/fmicb.2019.02805

Leclercia adecarboxylata From Human Gut Flora Carries mcr-4.3 and blaIMP-4-Bearing Plasmids


Immunocompromised Patients
10.1097/MAO.0000000000002343

Mycotic Pseudoaneurysm of Internal Carotid Artery Induced by Skull Base Osteomyelitis.


Immunocompromised Patients
10.1177/0049475518801618

Screening of toxoplasmosis in cancer patients: a concern


Immunocompromised Patients
10.1016/j.regg.2019.04.009

[Cytomegalovirus colitis in an immunocompetent elderly patient].


Immunocompromised Patients
10.1097/QCO.0000000000000586

Newer approaches in diagnosis of diarrhea in immunocompromised patients.


Immunocompromised Patients
10.1111/ejh.13366

Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis


Immunocompromised Patients
10.11604/pamj.supp.2019.32.1.13297

Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014


Immunocompromised Patients
10.20546/IJCMAS.2019.806.139

Glactomannan Index as a Rapid Diagnostic Tool for Invasive Pulmonary Aspergillosis in Patients with Chronic Lung Diseases


Immunocompromised Patients
10.1093/cid/ciz835

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?


Immunocompromised Patients
10.1016/J.SCRS.2019.100689

Diverticulitis in the immunocompromised patient


Immunocompromised Patients
10.1128/AEM.00105-19

Disruption of Quorum Sensing and Virulence in Burkholderia cenocepacia by a Structural Analogue of the cis-2-Dodecenoic Acid Signal


Immunocompromised Patients
10.1007/s15010-019-01329-y

Herpes simplex vegetans in a patient with primary myelofibrosis


Immunocompromised Patients
10.4103/ijo.IJO_43_19

Fulminant scleral abscess secondary to infected scleral buckle with Moraxella species


Immunocompromised Patients
10.1007/978-3-030-00362-3_9

Primary CNS Lymphoma


Immunocompromised Patients
10.1155/2019/5057071

Leclercia adecarboxylata Cholecystitis with Septic Shock in Immunocompetent Patient


Immunocompromised Patients
10.1186/s12879-019-3938-y

Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients


Immunocompromised Patients
10.1007/978-3-030-10811-3_10

Immune Response in Human Pathology: Infections Caused by Bacteria, Viruses, Fungi, and Parasites


Immunocompromised Patients
10.1007/s11481-019-09877-8

Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML)


Immunocompromised Patients
10.1128/JCM.01592-19

Cerebrospinal Fluid Findings Are Poor Predictors of Appropriate FilmArray Meningitis/Encephalitis Panel Utilization in Pediatric Patients


Immunocompromised Patients
10.1016/j.ad.2018.04.011

Primary Cutaneous Nocardiosis in a Man Treated With Certolizumab.


Immunocompromised Patients
10.15171/ajcmi.2019.03

The Prevalence of Virulence Factors in Human and Environmental Isolates of Pseudomonas aeruginosa


Immunocompromised Patients
10.3390/v11060483

Isolation of Subtype 3c, 3e and 3f-Like Hepatitis E Virus Strains Stably Replicating to High Viral Loads in an Optimized Cell Culture System


Immunocompromised Patients
10.1007/s00436-019-06445-0

Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening


Immunocompromised Patients
10.1007/978-3-030-13035-0_7

Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata.


Immunocompromised Patients
10.1016/J.PATOL.2019.02.008

Esophageal tuberculosis in an HIV-positive patient mimicking a spindle cell tumor.


Immunocompromised Patients
10.3389/fmicb.2019.02589

Trichophyton rubrum Elicits Phagocytic and Pro-inflammatory Responses in Human Monocytes Through Toll-Like Receptor 2


Immunocompromised Patients
10.1038/s41467-019-09915-2

Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor


Immunocompromised Patients
10.1101/715045

Glucuronoxylomannan in the Cryptococcus species capsule as a target for CAR+ T-cell therapy


Immunocompromised Patients
10.1007/s00330-019-06235-3

Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography


Immunocompromised Patients
10.30978/UNJ2019-2-12

Системи інтрагангліонарного та інтранейронального контролю над латентними α-герпесвірусами у сенсорних гангліях периферичної нервової системи


Immunocompromised Patients
10.21608/JESP.2019.68196

MILÁČEK-VITOVEC STAINING METHOD VERSUS CONVENTIONAL AND MOLECULAR ONES FOR DIAGNOSIS OF CYCLOSPORA CAYETANENSIS INFECTION


Immunocompromised Patients
10.1177/2324709619834578

Cryptococcal Meningitis in an Apparent Immunocompetent Patient


Immunocompromised Patients
10.1080/23744235.2019.1687933

Capnocytophaga canimorsus – a potent pathogen in immunocompetent humans – systematic review and retrospective observational study of case reports


Immunocompromised Patients
10.3201/eid2509.190430

Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum


Immunocompromised Patients
10.21608/EJRSA.2018.5656.1054

Expression of dnak, groES and cps Genes in Irradiated Klebsiella pneumoniae Strains Isolated from UTI Egyptian Patients


Immunocompromised Patients
10.3881/j.issn.1000-503X.11183

[Clinical and Laboratory Characteristics of Disseminated Non-tuberculous Mycobacterial Disease].


Immunocompromised Patients
10.1016/j.jemermed.2019.10.019

One Health and Streptococcus Canis in the Emergency Department: A Case of Cellulitis and Bacteremia in an Immunocompromised Patient Treated With Etanercept.


Immunocompromised Patients
10.1101/cshperspect.a033464

Innate Immunity to Enteric Hepatitis Viruses.


Immunocompromised Patients
10.1007/s00108-019-0616-5

Pneumocystis-jirovecii-Pneumonie – eine opportunistische Infektion im Wandel


Immunocompromised Patients
10.1111/1346-8138.14874

Case of ultraviolet B‐mediated photosensitivity during the administration of voriconazole


Immunocompromised Patients
10.1007/s00134-019-05826-4

Diffuse varicella zoster virus reactivation in critically ill immunocompromised patient


Immunocompromised Patients
10.1016/j.ijmm.2019.151336

Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.


Immunocompromised Patients
10.3390/molecules24132375

Conserved G-Quadruplexes Regulate the Immediate Early Promoters of Human Alphaherpesviruses


Immunocompromised Patients
10.1093/ofid/ofz343

Trichosporon japonicum Fungemia and Ventricular Assist Device Infection in an Immunocompetent Patient


Immunocompromised Patients
10.1016/J.BBMT.2018.12.489

Communication and a Team Approach for Maintaining Patient, Visitor and Occupational Safety during Administration of Aerosolized Ribavirin


Immunocompromised Patients
10.1080/21505594.2019.1568174

Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis


Immunocompromised Patients
10.1136/bcr-2019-230003

Rare presentation of cryptococcal meningitis in an immunocompetent patient


Immunocompromised Patients
10.18502/cmm.5.1.536

Fatal rhinocerebral mucormycosis in a patient with ulcerative colitis receiving azathioprine and corticosteroid


Immunocompromised Patients
10.1111/odi.13216

Association between oral candidiasis and bacterial pneumonia: a retrospective study.


Immunocompromised Patients
10.1101/553958

Serologic evidence of seasonal influenza A and B viruses in HIV patients on combined antiretroviral therapy in Lagos, Nigeria